Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

Iptacopan, an oral inhibitor of factor B, increased hemoglobin levels in patients with persistent anemia despite anti-C5 therapy and in patients without previous complement-inhibitor therapy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2024-03, Vol.390 (11), p.994-1008
Hauptverfasser: Peffault de Latour, Régis, Röth, Alexander, Kulasekararaj, Austin G., Han, Bing, Scheinberg, Phillip, Maciejewski, Jaroslaw P., Ueda, Yasutaka, de Castro, Carlos M., Di Bona, Eros, Fu, Rong, Zhang, Li, Griffin, Morag, Langemeijer, Saskia M.C., Panse, Jens, Schrezenmeier, Hubert, Barcellini, Wilma, Mauad, Vitor A.Q., Schafhausen, Philippe, Tavitian, Suzanne, Beggiato, Eloise, Chew, Lee Ping, Gaya, Anna, Huang, Wei-Han, Jang, Jun Ho, Kitawaki, Toshio, Kutlar, Abdullah, Notaro, Rosario, Pullarkat, Vinod, Schubert, Jörg, Terriou, Louis, Uchiyama, Michihiro, Wong Lee Lee, Lily, Yap, Eng-Soo, Sicre de Fontbrune, Flore, Marano, Luana, Alashkar, Ferras, Gandhi, Shreyans, Trikha, Roochi, Yang, Chen, Liu, Hui, Kelly, Richard J., Höchsmann, Britta, Kerloeguen, Cécile, Banerjee, Partha, Levitch, Rafael, Kumar, Rakesh, Wang, Zhixin, Thorburn, Christine, Maitra, Samopriyo, Li, Shujie, Verles, Aurelie, Dahlke, Marion, Risitano, Antonio M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Iptacopan, an oral inhibitor of factor B, increased hemoglobin levels in patients with persistent anemia despite anti-C5 therapy and in patients without previous complement-inhibitor therapy.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa2308695